<DOC>
	<DOCNO>NCT00980252</DOCNO>
	<brief_summary>This randomize pilot study intervention base principle Cognitive Behavioral Therapy ( CBT ) . This intervention Health Dialogue Intervention ( HDI ) compare traditional medical model psychoeducation know Team Solutions ( TS ) first-episode schizophrenia patient . Outcomes include acceptance HDI TS , compare adherence attitude end treatment intervention , compare time first episode nonadherence .</brief_summary>
	<brief_title>Medication Adherence Schizophrenia : Development CBT-Based Intervention</brief_title>
	<detailed_description>Overview : Many people recover first-episode schizophrenia typically respond well initial course antipsychotic medication ; however , study indicate nonadherence rate soar high 90 % first year improve time . To date , effective psychosocial intervention improve adherence reduces adverse consequence nonadherence occur . Thus , imperative develop new intervention improve medication adherence improve clinical outcome patient recover first-episode schizophrenia . This study pilot intervention specifically suit patient first-episode schizophrenia base principle Cognitive Behavioral Therapy ( CBT ) . This focus adherence perspective patient . Methods : This study compare effectiveness standard psychoeducation program [ Team Solutions ( TS ) ] CBT approach know Health Dialogue Intervention ( HDI ) . Consenting patient receive 4 week stabilization assessment period randomize prospective , random-assignment study compare effectiveness TS HDI improve medication adherence patient recover first-episode schizophrenia .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<criteria>There 2 step inclusion/exclusion criterion , first assess overall eligibility enter study , , continue outpatient treatment schizophrenia , schizophreniform disorder , schizoaffective disorder . Inclusion criterion entry Evaluation Phase : 1 . Between 1645 year age 2 . A provisional clinical diagnosis schizophreniform disorder , schizophrenia , schizoaffective disorder last 6 month 3 . Discharge inpatient unit treatment psychotic symptom must occur last 6 month , , never hospitalize , initial treatment start last 6 month 4 . Able fully participate informed consent process 5 . The patient judge appropriate candidate ongoing outpatient followup Firstepisode Treatment Program Psychotic Disorders Program UIC Exclusion criterion Evaluation Phase : 1 . Unable understand inform consent process 2 . A history nonresponse prior antipsychotic trial longterm inpatient treatment clozapine recommend 3 . Prior treatment clozapine 4 . Discharge inpatient treatment psychotic symptom , initial treatment , provisional diagnosis schizophrenia , schizoaffective disorder , schizophreniform occur 6 month enrollment evaluation phase 5 . Pregnancy state goal become pregnant 6 . Will live close enough medical center return followup visit assessment 7 . History geographic instability judge unlikely patient reside area 8 . Currently arrest felony , arrest deem likely near future 9 . Currently receive medication objection court order 10 . Currently receive treatment another research protocol Inclusion Criteria Treatment Intervention Phase : 1 . Willingness transition receive evaluation future pharmacologic treatment Psychotic Disorders Program UIC 2 . Has capacity understand risk benefit participate randomize psychosocial trial 3 . Willingness sign inform consent go Treatment Intervention Phase 4 . Is able complete posttest understanding nature study entail , potential risk benefit study participation 5 . Is willing therapy session record fidelity assessments 6 . Is willing receive followup independent assessment adherence status , include separate interview train independent raters , contact outpatient pharmacy pharmacy refill record Exclusion criterion Treatment Intervention Phase : 1 . Diagnosis inpatient treatment psychotic symptom occur 6 month date enrollment evaluation phase 2 . Acutely psychotic individual may participate therapy benefit symptom severe 3 . Has drop treatment program locate followup appointment 4 . Stated refusal come least one clinical evaluation appointment PDP , `` show '' least three consecutive appointment 5 . Judged significant imminent risk harm self others* 6 . Ongoing active substance alcohol use control Evaluation Phase , along refusal referral `` dual diagnosis '' treatment program substance abuse problem 7 . Remains enrol another research protocol UIC* 8 . Unwilling consider additional psychotherapeutic intervention beyond coming service medication management appointment 9 . Baseline PANSS total score ≥ 90 , individual PANSS item conceptual disorganization ( item P2 ) , excitement ( P4 ) , hostility ( P7 ) ≥ 5 ( moderately severe ) * 10 . Judged require additional concrete case management service support medication adherence* 11 . Receives antipsychotic coercive condition ( e.g . inpatient outpatient commitment ) * Note : The exclusion criterion ( * ) may present part Evaluation Phase would need resolve within 4 week time period permit Evaluation Phase prior Treatment Intervention Phase study entry .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Cognitive Behavioral Therapy</keyword>
	<keyword>Compliance</keyword>
	<keyword>Medication Adherence</keyword>
	<keyword>Psychotic Disorders</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Outcomes</keyword>
	<keyword>Psychoeducation</keyword>
	<keyword>Adherence Attitudes</keyword>
	<keyword>Intervention</keyword>
	<keyword>Nonadherence</keyword>
	<keyword>Schizophrenia Disorders Psychotic Features</keyword>
</DOC>